In our study, patients not responding to treatment had marginally significant higher median MMDs at baseline and a significantly higher consumption of analgesics compared with responders.
← all excerpts
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy.
1
—
—